Page 78 - JCTR-11-4

Journal of Clinical and
Translational Research Adherence and psoriasis severity in Brazil

doi: 10.1186/s12875-022-01719-6 psoriasis: Strategies to ensure treatment adherence. Psoriasis
24. Devaux S, Castela A, Archier E, et al. Adherence to topical (Auckl). 2015;5:109-115.
treatment in psoriasis: A systematic literature review. J Eur doi: 10.2147/PTT.S54070
Acad Dermatol Venereol. 2012;26 Suppl 3:61-67.
30. Zaghloul SS, Goodfield MJ. Objective assessment of
doi: 10.1111/j.1468-3083.2012.04525.x compliance with psoriasis treatment. Arch Dermatol.
25. Piragine E, Petri D, Martelli A, et al. Adherence and 2004;140(4):408-414.
persistence to biological drugs for psoriasis: Systematic doi: 10.1001/archderm.140.4.408
review with meta-analysis. J Clin Med. 2022;11(6):1506.
31. Bewley A, Burrage DM, Ersser SJ, Hansen M, Ward C.
doi: 10.3390/jcm11061506 Identifying individual psychosocial and adherence support
26. Aleshaki JS, Cardwell LA, Muse ME, Feldman SR. needs in patients with psoriasis: A multinational two-stage
Adherence and resource use among psoriasis patients qualitative and quantitative study. J Eur Acad Dermatol
treated with biologics. Expert Rev Pharmacoecon Outcomes Venereol. 2014;28(6):763-770.
Res. 2018;18(6):609-617.
doi: 10.1111/jdv.12174
doi: 10.1080/14737167.2018.1512408
32. Bewley A, Page B. Maximizing patient adherence for optimal
27. Bronckers I, Paller AS, West DP, et al. A comparison outcomes in psoriasis. J Eur Acad Dermatol Venereol.
of psoriasis severity in pediatric patients treated with 2011;25 Suppl 4:9-14.
methotrexate vs biologic agents. JAMA Dermatol.
2020;156(4):384-392. doi: 10.1111/j.1468-3083.2011.04060.x
doi: 10.1001/jamadermatol.2019.4835 33. Ros S, Puig L, Carrascosa JM. Cumulative life course
impairment: The imprint of psoriasis on the patient’s life.
28. Dommasch ED, Lee MP, Joyce CJ, Garry EM, Gagne JJ. Drug Actas Dermosifiliogr. 2014;105(2):128-134.
utilization patterns and adherence in patients on systemic
medications for the treatment of psoriasis: A retrospective, doi: 10.1016/j.ad.2013.02.009
comparative cohort study. J Am Acad Dermatol. 34. Zhu B, Jing M, Yu Q, Ge X, Yuan F, Shi L. Treatments in
2018;79(6):1061-1068. e1. psoriasis: From standard pharmacotherapy to nanotechnology
doi: 10.1016/j.jaad.2018.06.053 therapy. Postepy Dermatol Alergol. 2022;39(3):460-471.
29. Yelamos O, Ros S, Puig L. Improving patient outcomes in doi: 10.5114/ada.2021.108445

Volume 11 Issue 4 (2025) 72 doi: 10.36922/jctr.24.00057